| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP, CFO and Treasurer
1 company
Spellman David A is a SVP, CFO and Treasurer at AKBA. Recent filings cover 0 purchases and 7 sales. Those positions are worth an estimated $477K at current prices.
Our model assigns Spellman David A a middling insider score of 52/100, based on 6 past trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of +2.2%.
Spellman David A's largest disclosed position is in AKBA as SVP, CFO and Treasurer, worth about $477K. The recent filings there lean toward selling, a net 87,309 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 16, 2023 | AKBA Akebia Therapeutics, Inc. | SVP, CFO and Treasurer | Sell | 63,567 | $1.07 | $67,889.56 | -12.5% | +25.7% | +12.4% | |
| Mar 1, 2023 | AKBA Akebia Therapeutics, Inc. | SVP, CFO and Treasurer | Sell | 7,210 | $0.88 | $6,326.78 | -1.4% | +4.8% | +72.7% | |
| Feb 27, 2023 | AKBA Akebia Therapeutics, Inc. | SVP, CFO and Treasurer | Sell | 7,539 | $0.81 | $6,130.71 | -1.4% | +17.5% | +101.1% | |
| Mar 1, 2022 | AKBA Akebia Therapeutics, Inc. | SVP, CFO and Treasurer | Sell | 8,203 | $2.16 | $17,688.59 | -6.0% | -82.8% | -57.4% | |
| Apr 1, 2021 | AKBA Akebia Therapeutics, Inc. | SVP, CFO and Treasurer | Sell | 790 | $3.40 | $2,686.00 | -1.0% | +13.8% | -79.9% |